NASDAQ:PDCO
Delisted

Patterson Companies Stock News

etoro logo Buy PDCO
*Your capital is at risk
$31.33
+0 (+0%)
At Close: Jul 16, 2025
Exact Sciences (NASDAQ:EXAS) initiated with an Outperform rating and a $70 (25% upside) price target at Evercore ISI.Health Catalyst (NASDAQ:HCAT) initiated with a Buy rating and a $40 (47% upside) pr
Bank of New York Mellon Corp decreased its position in shares of Patterson Companies, Inc. (NASDAQ:PDCO) by 5.8% during the 4th quarter, according to the company in its most recent disclosure with the
AQR Capital Management LLC trimmed its position in Patterson Companies, Inc. (NASDAQ:PDCO) by 38.0% in the fourth quarter, HoldingsChannel reports. The firm owned 257,266 shares of the company’s sto
McKesson (MCK) continues to gain traction from its multi-year strategic growth initiative and distribution solutions segment.
McKesson (MCK) continues to gain traction from its multi-year strategic growth initiative and distribution solutions segment.
In a report released yesterday, Steven Valiquette from Barclays maintained a Hold rating on Henry Schein (HSIC), with a price target of $57.00. The

McKesson (MCK) Gets a Hold Rating from Barclays

10:56am, Tuesday, 31'st Mar 2020
Barclays analyst Steven Valiquette maintained a Hold rating on McKesson (MCK) yesterday and set a price target of $163.00. The company's shares closed
Amalgamated Bank raised its holdings in Patterson Companies, Inc. (NASDAQ:PDCO) by 9.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC

Centene (CNC) Receives a Buy from Barclays

12:22am, Monday, 30'th Mar 2020
Barclays analyst Steven Valiquette maintained a Buy rating on Centene (CNC) on March 27 and set a price target of $82.00. The company's shares closed last

Centene (CNC) Receives a Buy from Barclays

12:22am, Monday, 30'th Mar 2020
Barclays analyst Steven Valiquette maintained a Buy rating on Centene (CNC – Research Report) on March 27 and set a
In a report issued on March 27, Steven Valiquette from Barclays maintained a Hold rating on Molina Healthcare (MOH), with a price target of $157.00. The
In a report issued on March 27, Steven Valiquette from Barclays maintained a Hold rating on Molina Healthcare (MOH –
Barclays analyst Steven Valiquette maintained a Buy rating on Cigna (CI) on March 27 and set a price target of $232.00. The company's shares closed last
Barclays analyst Steven Valiquette maintained a Buy rating on Cigna (CI – Research Report) on March 27 and set a
Barclays analyst Steven Valiquette maintained a Buy rating on UnitedHealth (UNH) on March 27 and set a price target of $322.00. The company's shares
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE